VAERS Explorer
Back to explore

Report #2893656

Received Apr 22, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
IN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RABRABIES (RABAVERT)NOVARTIS VACCINES AND DIAGNOSTICSUNK50632-010-01—

Symptoms (1)

Product packaging issue

Symptom narrative

Rabies vaccine from manufacturer is packaged with 2 x 25 G needles. They are specifically labeled "1 x 25G needle for reconstitution" and "1 x 25 G needle for administration". Neither needles contact any patient/staff safety features to prevent needle stick injuries. The syringe is luer-lock, so it seems as though they should either not include an administration needle and recommend staff uses a normal 25G "flip-cap" or vanish point syringe. Staff is at an increased risk for needle-stick injuries on an IM injection when following the package insert.